Skip to main content
. 2016 Sep 22;22(1):70–78. doi: 10.1007/s10147-016-1039-0

Table 4.

Treatment-related adverse events, all grades (≥30 %) and grade ≥3 (≥5 %)

All grades (≥30 %) Grade ≥3 (≥5 %)
n (%) n (%)
Rash 85 (82.5) 15 (14.6)
Diarrhea 82 (79.6) 0 (0.0)
Dry skin 82 (79.6) 0 (0.0)
Paronychia 69 (67.0) 0 (0.0)
Stomatitis 65 (63.1) 0 (0.0)
Pruritus 67 (65.0) 0 (0.0)
Decreased appetite 35 (34.0) 0 (0.0)
ALT increased 33 (32.0) 15 (14.6)

ALT alanine aminotransaminase